| 70.40 | -1.29 / -1.80% |
Data as of 3:59pm ET | Day’s Change |
| 70.40 | |
Volume: 11.0K |
| Illumina Inc. (ILMN): Today's Featured Drugs Winner Jun 17 / TheStreet.com | Do You Know the Top Stocks of the Last Decade? Jun 13 / MotleyFool.com |
| Is Sequenom Stock Destined for Greatness? Jun 13 / MotleyFool.com | Judgment Day for Myriad Genetics Jun 05 / MotleyFool.com |
| Previous close | 71.69 |
| Today’s open | 71.69 |
| Day’s range | 70.27 - 72.35 |
| Volume | 660,244 |
| Average volume (3 months) | 1,343,636 |
| Market cap | $8.9B |
| Dividend yield | -- |
| Earnings growth (last year) | +82.26% |
| Earnings growth (this year) | +5.98% |
| Earnings growth (next 5 years) | +16.81% |
| Revenue growth (last year) | +8.81% |
| P/E ratio | 93.9 |
| Price/Sales | 5.86 |
| Price/Book | 6.74 |
| Today’s change | Today’s % change | |
|---|---|---|
| WATWaters Corp | -1.68 | -1.65% |
| MTDMettler-Toledo Inter... | -3.44 | -1.59% |
| QGENQiagen NV | -0.12 | -0.61% |
| PKIPerkinElmer Inc | -0.75 | -2.18% |
| Next reporting date | July 23, 2013 |
| EPS forecast (this quarter) | $0.40 |
| Annual revenue (last year) | $1.1B |
| Annual profit (last year) | $151.3M |
| Net profit margin | 13.17% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Jay T. Flatley |
Senior Vice President- Operations William Bonnar, MBA |
Corporate headquarters San Diego, California |
